Search

everythinglearnresearchcommunity

for

Search:↓

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Stem-cell therapy shows promise for skin conditions but needs more research.

Hormonal changes and social stress may link lupus and eating disorders in teens.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Hair conditions can be linked to diabetes and affect psychological health.

Different rheumatological diseases can cause specific skin problems.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

A woman's scalp condition improved with specific ointment after a hair piece caused skin issues.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.